
Highlights from ISA 2024: the importance of early diagnosis in AL amyloidosis, trials in progress & patient selection for SCT
VJHemOnc Podcast
00:00
Discussion on Important Clinical Trials in AL Amyloidosis
This chapter discusses important clinical trials focusing on Venetoclax, Exazomib, and dexamethasone in relapsed AL amyloidosis, a bispecific antibody ABBV383 for refractory multiple myeloma, and a trial evaluating stem cell transplantation in newly diagnosed AL amyloidosis patients.
Transcript
Play full episode